Real world data to identify target population for new CAR-T therapies

被引：0
|
作者：
Belleudi, Valeria [1 ]
Trotta, Francesco [2 ]
Fortinguerra, Filomena [2 ]
Poggi, Francesca Romana [1 ]
Olimpieri, Odoardo [2 ]
Santelli, Enrica [1 ]
Cozzi, Ilaria [1 ]
Michelozzi, Paola [1 ]
Addis, Antonio [1 ]
机构：
[1] Lazio Reg Hlth Serv, Rome, Italy
[2] Italian Med Agcy AIFA, Rome, Italy
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4254
引用
收藏
页码：162 / 162
页数：1
相关论文
共 50 条
  • [31] Clinical evidence of immunogenicity of CAR-T cell therapies and its implication in the clinical development of CAR-T drug products
    Alfar, Hammodah R.
    Chen, Cecil
    Lachacz, Eric
    Tang, Weifeng
    Zhang, Yuqian
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [32] Real World Outcomes with Evolving Management of Cytokine Release Syndrome in CAR-T Therapy
    Bansal, Radhika
    Corraes, Andre
    Shaw, Monica
    Holmes, Lucy
    Kosobud, Allison
    Haugen, Kelsey L.
    Khurana, Arushi
    Hampel, Paul J.
    Durani, Urshila
    Hayman, Suzanne R.
    Wang, Yucai
    Binder, Moritz
    Paludo, Jonas
    Kenderian, Saad S.
    Bennani, N. Nora
    Johnston, Patrick B.
    Ansell, Stephen M.
    Lin, Yi
    BLOOD, 2024, 144 : 2274 - 2275
  • [33] Real-world barriers to CAR-T access: A Canadian referral center perspective
    Shi, Steven
    Laverdure, Eva
    Cohen, Sandra R. A.
    Veilleux, Olivier
    Lachance, Silvy
    Mollica, Luigina
    Fleury, Isabelle
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] The new generations of CAR-T cells
    Messaoudi, Djamel
    Perez, Franck
    Gouveia, Zelia
    M S-MEDECINE SCIENCES, 2024, 40 (11): : 848 - 857
  • [35] Newly established CAR-T target antigen luciferase reporter cell lines facilitate CAR-T development
    Foulke, John
    Della Fera, Brian
    Chen, Luping
    Tian, Fang
    CANCER RESEARCH, 2022, 82 (12)
  • [36] In Search of an Ideal CAR-T Cell Antigen Target
    Carvalho Barros, Luciana Rodrigues
    CRITICAL REVIEWS IN IMMUNOLOGY, 2021, 41 (01) : 69 - 76
  • [37] CAR-T Cell Therapies From the Transfusion Medicine Perspective
    Fesnak, Andrew
    Lin, ChieYu
    Siegel, Don L.
    Maus, Marcela V.
    TRANSFUSION MEDICINE REVIEWS, 2016, 30 (03) : 139 - 145
  • [38] Review of CAR-T therapies' reports to the pharmacovigilance centre of Cantabria
    Marana, I. Mazon
    Cuellar Gomez, D. Z.
    Gonzalez Ruiz, M.
    Sanchez Escamilla, M.
    Cerezo Martin, J. M.
    Cadenas Mancenido, A.
    Garcia Saiz, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 : 35 - 35
  • [39] Developing CAR-T cells therapies : Is the European law adequate ?
    Pichereau, D.
    Chabannon, C.
    Rial-Sebbag, E.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 605 - 606
  • [40] Phosphatidylserine as a tumor target for CAR-T cell therapy
    Martin-Otal, Celia
    Sanchez-Moreno, Ines
    Gomez-Moron, Alvaro
    Castro, Carla
    Casares, Noelia
    Navarro, Flor
    Gorraiz, Marta
    Justicia-Lirio, Pedro
    Pareja, Felix
    Collantes, Maria
    Penuelas, Ivan
    Inarrairaegui, Mercedes
    Sangro, Bruno
    Vivas, Isabel
    Larrayoz, Marta
    Rodriguez, Juan Roberto
    Prosper, Felipe
    Hervas-Stubbs, Sandra
    Martin-Cofreces, Noa
    Lasarte, Juan Jose
    Lozano, Teresa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
12345